Clinical Trial Update: Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing zotarolimus-eluting, sirolimus-eluting, and paclitaxel-eluting stents for coronary lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher Sirolimus-Eluting Stent (sirolimus-eluting stent)
• Endeavor zotarolimus-eluting stent (zotarolimus)
• TAXUS Paclitaxel-Eluting Stent (paclitaxel-eluting stent)

Snippet

Sponsor: Seung-Jung Park | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED